Cargando…

Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

Rapamycin, an inhibitor of mTOR kinase, increased median lifespan of genetically heterogeneous mice by 23% (males) to 26% (females) when tested at a dose threefold higher than that used in our previous studies; maximal longevity was also increased in both sexes. Rapamycin increased lifespan more in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Richard A, Harrison, David E, Astle, Clinton M, Fernandez, Elizabeth, Flurkey, Kevin, Han, Melissa, Javors, Martin A, Li, Xinna, Nadon, Nancy L, Nelson, James F, Pletcher, Scott, Salmon, Adam B, Sharp, Zelton Dave, Van Roekel, Sabrina, Winkleman, Lynn, Strong, Randy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032600/ https://www.ncbi.nlm.nih.gov/pubmed/24341993 http://dx.doi.org/10.1111/acel.12194

Ejemplares similares

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
por: Harrison, David E., et al.
Publicado: (2009)

Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
por: Harrison, David E, et al.
Publicado: (2014)

Adaptations to chronic rapamycin in mice
por: Dodds, Sherry G., et al.
Publicado: (2016)

Rapamycin extends life span of Rb1(+/−) mice by inhibiting neuroendocrine tumors
por: Livi, Carolina B., et al.
Publicado: (2013)

Glycine supplementation extends lifespan of male and female mice
por: Miller, Richard A., et al.
Publicado: (2019)

Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
por: Strong, Randy, et al.
Publicado: (2020)

Acarbose improves health and lifespan in aging HET3 mice
por: Harrison, David E., et al.
Publicado: (2019)

Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
por: Ross, Corinna, et al.
Publicado: (2015)

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
por: Strong, Randy, et al.
Publicado: (2016)

Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain
por: Gong, Huan, et al.
Publicado: (2015)

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
por: Strong, Randy, et al.
Publicado: (2022)

Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
por: Fok, Wilson C., et al.
Publicado: (2014)

17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
por: Harrison, David E., et al.
Publicado: (2021)

Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
por: Siegmund, Stephanie E, et al.
Publicado: (2017)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

Is Rapamycin a Dietary Restriction Mimetic?
por: Unnikrishnan, Archana, et al.
Publicado: (2020)

Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes
por: Reifsnyder, Peter C., et al.
Publicado: (2016)

SEX DIFFERENCES IN LIFESPAN RESPONDING TO EARLY AND LATE ONSET DIETARY RESTRICTION
por: Jiang, Nisi, et al.
Publicado: (2022)

Rapamycin prolongs female reproductive lifespan
por: Luo, Li-li, et al.
Publicado: (2013)

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
por: Weiss, Roxanne, et al.
Publicado: (2018)

Target of rapamycin signalling mediates the lifespan-extending effects of dietary restriction by essential amino acid alteration
por: Emran, Sahar, et al.
Publicado: (2014)

The Possible Cellular Mechanism for Extending Lifespan of Mice with Rapamycin
por: Li, Shulin
Publicado: (2009)

Target of rapamycin activation predicts lifespan in fruit flies
por: Scialò, Filippo, et al.
Publicado: (2015)

The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation
por: Bjedov, Ivana, et al.
Publicado: (2020)

Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver
por: Fok, Wilson C, et al.
Publicado: (2014)

Short-Term Treatment With Rapamycin and Dietary Restriction Have Overlapping and Distinctive Effects in Young Mice
por: Fok, Wilson C., et al.
Publicado: (2013)

Unlike dietary restriction, rapamycin fails to extend lifespan and reduce transcription stress in progeroid DNA repair‐deficient mice
por: Birkisdóttir, María B., et al.
Publicado: (2021)

Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
por: Rodriguez, Karl A., et al.
Publicado: (2014)

Rapamycin/metformin co‐treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice
por: Reifsnyder, Peter C., et al.
Publicado: (2022)

Rapamycin-induced metabolic defects are reversible in both lean and obese mice
por: Liu, Yuhong, et al.
Publicado: (2014)

Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2013)

Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
por: Minton, Dennis M., et al.
Publicado: (2021)

Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle
por: Ham, Daniel J., et al.
Publicado: (2022)

Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
por: Komarova, Elena A., et al.
Publicado: (2012)

Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila
por: Schinaman, Joseph M., et al.
Publicado: (2019)

DNA- and telomere-damage does not limit lifespan: evidence from rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2021)

As predicted by hyperfunction theory, rapamycin treatment during development extends lifespan
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Correction for: Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
por: Ye, Lan, et al.
Publicado: (2020)

NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model
por: Nadon, Nancy L., et al.
Publicado: (2016)

Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
por: Minton, Dennis M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2ndpsnejreacfgt4i4puse5ll